Upgrade to SI Premium - Free Trial

Sensei Biotherapeutics, Inc. (SNSE) Tops Q3 EPS by 2c

November 14, 2024 7:35 AM

Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) reported Q3 EPS of ($0.29), $0.02 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Sensei Biotherapeutics, Inc. (SNSE) click here.

Categories

Earnings